BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
| Business Activity | PASS |
| Debt Ratio | N/A |
| Cash Ratio | N/A |
| Receivables Ratio | N/A |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
$1.2B
3.31
1.970
10
$101.7M
$14.9M
1.10
10.02
0.1%
155
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($32.30, 10 analysts) | |||
| 10 | $245.00 | +$78.00 (32%) | 2.1R |
| 50 | $1,225.00 | +$390.00 (32%) | 2.1R |
| 100 | $2,450.00 | +$780.00 (32%) | 2.1R |
- High beta (1.97) — amplifies market moves by 1.97x
- Elevated short interest (10.02 days to cover)
- Valuation stretched on forward earnings
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| ARKG | 0.591 |
| IWM | 0.563 |
| RGEN | 0.544 |
| ADJEX | 0.508 |
| RVT | 0.495 |
| Ticker | Correlation |
|---|---|
| SUKOON.AE | -0.172 |
| CBOE | -0.151 |
| BAES.L | -0.148 |
| LPTVQ | -0.139 |
| COL.AX | -0.139 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.